Learn as if you will live forever, live like you will die tomorrow.

   +1 555 87 89 56   80 Harrison Lane, FL 32547
Contact Us
Contact Us
Enable Injections-enFuse-drug-delivery-innovation

Sanofi announces partnership with Enable Injections, Inc. on subcutaneous delivery for Sarclisa®

In a press release today, Sanofi announces partnership with Enable Injections, Inc. on subcutaneous delivery for Sarclisa®.

Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myeloma

Enable Injections is delighted with the public news, announcing our partnership with Sanofi for the subcutaneous formulation and delivery of the anti-CD38 antibody Sarclisa®, to treat patients with multiple myeloma (MM).

“For the Sarclisa® subcutaneous formulation delivery, Sanofi has partnered with drug delivery technology innovator company Enable Injections, Inc. to advance the development of a subcutaneous delivery for Sarclisa® with the goal of offering a unique patient-centric treatment experience.” Click to read the full press release.

Enable Injections-enFuse-drug-delivery-innovation

To learn more about partnering with Enable Injections and our innovative enFuse® drug delivery technology, contact us.

Sign Up For Our Newsletter

Stay up on the latest enFuse® technology, partnerships, events, and news by signing up to receive the once-monthly Enable Injections Newsletter direct to your inbox. 

This field is hidden when viewing the form

Next Steps: Sync an Email Add-On

To get the most out of your form, we suggest that you sync this form with an email add-on. To learn more about your email add-on options, visit the following page (https://www.gravityforms.com/the-8-best-email-plugins-for-wordpress-in-2020/). Important: Delete this tip before you publish the form.
This field is for validation purposes and should be left unchanged.